Cite

HARVARD Citation

    Leppä, S. et al. (n.d.). DOSE‐DENSE CHEMOIMMUNOTHERAPY AND CNS PROPHYLAXIS IN PATIENTS WITH HIGH‐RISK DLBCL: A COMPARISON OF NORDIC CRY‐04 AND CHIC STUDIES. Hematological oncology. pp. 199-200. [Online]. 
  
Back to record